Canine Rabies Case In Reported In ParisAugust 17, 2011 A positive canine rabies case in Paris, France has been found in a puppy that orginated in Morocco, announced Dr. Jean Luc Angot, chief inspector of veterinary public health and chief veterinary officer for the Ministry of Food, Agriculture and Fisheries. A 2.5-month-old puppy adopted from Morocco July 11 was brought to France Aug. 1 without compliance with rabies health requirements, and the first signs of rabies occurred Aug. 1 or 2 and consisted of a change in behavior, Angot said. Due to a suspicion of rabies on Aug. 6, the animal was isolated and died Aug. 7. The Institute Pasteur in Paris, a National laboratory, made the rabies-positive report Aug. 11. The last French rabies case was diagnosed May 10, 2009. The animals in contact with the rabid puppy during the salivary excretion period include three cats, which will be euthanized. A vaccinated dog that lived in the same home is in isolation. Humans in contact with the dog during the salivary excretion of rabies virus are under the care of health services. Anti-rabies treatment has been administered as appropriate. Angot said he plans to submit a weekly follow-up report. …
SPONSORED CONTENTItch Relief for Canine PatientsA treatment for both allergic and atopic dermatitis that’s given just once a day. Visibly improves itch fast. + Learn More Now
Agribusiness Giant Cargill To Acquire Provimi For $2.16 BillionAugust 15, 2011“The combination of Cargill and Provimi would create a new, world-class animal nutrition offering with the expertise to offer customers a full range of enhanced products and services,” said Cargill vice chairman Paul Conway. “This acquisition would mark a significant step in Cargill’s animal nutrition growth strategy and underlines our commitment to continued long-term investment to meet the needs of our customers around the world.” Provimi, which has operations in 26 countries, produces premixes, additives and complete feeds. It recently sold its pet food business to Advent International for about $270 million. Cargill offers branded animal food for livestock producers and pet owners. It also provides feed ingredients to feed manufacturers. Company officials said the two businesses will complement each other well. “Bringing together the talents and expertise of both companies is expected to open up new innovation and market development opportunities,” said Todd Hall, Cargill’s corporate vice president. “Provimi’s excellence in cutting edge technology and applications, alongside Cargill’s global supply chain and market insights should enable us to develop and deliver a range of innovative, high quality products and services to customers.” Cargill is buying Provimi from private equity firm Permira, which acquired the company in 2007. Provimi chairman …
FDA Approves Atopica For CatsAugust 15, 2011 (cyclosporine oral solution, USP) modified, a treatment for chronic allergic dermatitis, has been approved by the FDA as the first OK'd for treating allergic dermatitis in cats. Allergic dermatitis causes itching, chewing, licking, skin lesions and hair loss. The drug’s manufacturer, Novartis Animal Health US Inc., previously acquired approval for a similar product used to treat atopic dermatitis in dogs. “Atopica for cats has the potential to change how our profession treats the itchy cat,” said Keith Hnilica, DVM, MS, MBA, Diplo. ACVD, who consults with Novartis and others on dermatological issues and authored Small Animal Dermatology: A Color Atlas and Therapeutic Guide 3rd edition. “For the first time, we have a safe, highly effective, approved treatment for cats with allergic dermatitis.” The company says Atopica relieves itching and scratching, with improvement seen in the first four weeks. After six weeks of treatment, 78 percent of cats were considered comfortable with satisfactory levels of grooming. The product, which will be available in late 2011, is also proven to reduce skin lesions. Novartis reports that approximately one-third of cats took the medicine in their food and two-thirds were dosed directly into the mouth in studies. The …
Oldest U.S. Mandrill Has Kidney SurgeryAugust 15, 2011 Veterinarians have successfully performed surgery on the oldest mandrill in the U.S. The surgery was performed by veterinarians at the Phoenix Zoo and Dr. Brian deGuzman, associate chief of cardiovascular surgery at St. Joseph's Heart and Lung Institute. Wucaria, a 34-year-old female mandrill, a species of monkey, had an abscess on her kidney. Phoenix Zoo veterinarians Gary West, DVM - EVP and Julie Swenson, DVM asked the zoo’s animal health advisory committee for help. The committee of veterinary and human specialists determined that Dr. deGuzman, an advisory volunteer, would assist with the removal of the monkey’s right kidney. “Dr. deGuzman is able to bring his specialized skills to the operating table, offering us opportunities to provide exceptional care to our Zoo’s animals,” Dr. West said. Three zoo veterinarians, a veterinary anesthesiologist, a veterinary surgeon, deGuzman and Jenifer Traylor, RN, participated in the June 2 surgery to remove Wucaria’s kidney. Wucaria is now comfortable and back on exhibit with her troupe. “A procedure like this requires an incredible amount of teamwork,” deGuzman said. “The Phoenix Zoo veterinarians are an extraordinary team and have been really accepting of the advice that I can provide on …
Lairmore Named UC Davis Dean Of Veterinary MedicineAugust 12, 2011 Michael D. Lairmore, DVM, PhD, Dipl. ACVP, ACVM, cancer researcher and administrator at The Ohio State University's (OSU) College of Veterinary Medicine (CVM), was named dean of UC Davis’ School of Veterinary Medicine. Dr. Lairmore, who will begin his UC Davis position Oct. 24, serves as associate dean for research and graduate studies at OSU’s veterinary medical college and as associate director of the university's Comprehensive Cancer Center. He is also a professor of veterinary biosciences in the CVM and has an adjunct appointment in molecular virology, immunology and medical genetics in the CVM. “It will be an honor to serve as dean of one of the premier institutions of its kind in the world,” Lairmore said. “I look forward to working with the faculty, alumni, staff and students as we build mission-focused programs from the strong foundations established at UC Davis.” As dean, Lairmore will preside over the William R. Pritchard Veterinary Medical Teaching Hospital, the California Animal Health and Food Safety Laboratory System and the Veterinary Medicine Extension program at UC Davis. <Home>
Penn Vet To Host Working Dog ConferenceAugust 12, 2011 Cindy Otto, DVM from the University of Pennsylvania’s Working Dog Center, will host a working dog conference Sept. 7 through Sept. 9 at the Pearl River Hilton in Pearl River, N.Y. The University of Pennsylvania Veterinary Working Dog Center 2011 International Conference titled, "Defining, Developing and Documenting Success in Working Dogs," will feature experts discussing topics regarding puppy selection and development, performance testing, certification and physical conditioning of working dogs. “Our mission is to share the knowledge available to improve the health, breeding and performance of working dogs,” Dr. Otto says. “Only about 30 percent of the dogs bred become successful working dogs and I hope the discussions from the conference will lead to improved solutions in ensuring their success on the field.” Otto monitors the health of the SAR dogs that participated in recovery operations for the World Trade Center and other sites related to Sept. 11, 2011 events. Out of 300 dogs that responded, about 25 percent are still living. The conference will take place in conjunction with ‘Finding One Another,’ a 10th anniversary tribute to the search and rescue (SAR) community of Sept. 11, 2011 whose efforts include paying tribute to the …
AHS Offers Plan For Heartworm Management During Immiticide ShortageAugust 11, 2011UPDATE: The FDA has granted Merial approval to import limited quantities of Immiticide from Europe. Click here to read this story. The American Heartworm Society (AHS) board and scientific committee has released an interim heartworm management plan to help veterinarians deal with heartworm cases in light of Immiticide being unavailable for the time being. “With Immiticide unavailable, veterinarians will need to take steps to carefully manage their heartworm-positive patients,” said Wallace Graham, DVM, president of AHS. “As the primary source of information on heartworm prevention and treatment for the veterinary practitioner, we have provided veterinarians with recommendations for appropriate patient care.” The goals of the interim plan endorsed by AHS include reducing potential pathology from the infection, maintaining the health of the heartworm-positive dog until it can be appropriately treated and preventing additional heartworm infection of the patient. Dr. Graham said the goal of this plan is not to eliminate the infection, but to manage the patient until Immiticide is available. The AHS plan entails pretreatment of heartworm-positive dogs to prevent shock and careful administration of a macrocyclic lactone heartworm preventive, followed by clinical observation for a minimum of eight hours. …
WestVet Performs First Hip Resurfacing Procedure In DogAugust 10, 2011 The WestVet Animal Emergency and Specialty Center in Garden City, Idaho is reportedly the first U.S. veterinary hospital to successfully perform a hip resurfacing procedure in a dog as a less invasive alternative to total hip replacement. The patient, who recently underwent the hip resurfacing procedure, is an English springer spaniel. After exhibiting mobility issues including stiffness and pain, Riggins the dog was examined by Jeff Brourman, DVM, MS, Dipl. ACVS, owner and chief of staff at WestVet Animal Emergency and Specialty Center. Dr. Brourman has been investigating the adaptation of the human procedure into veterinary medicine and determined Riggins was a good candidate for the procedure. Brourman and Sean Murphy, DVM, Dipl. ACVS, performed the procedure on Riggins. The dog recovered well from the procedure and is now able to ambulate comfortably. Riggins the dog recently underwent a hip resurfacing procedure, as a less invasive alternative to total hip replacement. “If the procedure continues to be successful, it may become a good alternative to total hip replacement in certain dogs suffering from hip dysplasia,” Brourman said. Brourman says he plans on performing more hip resurfacing procedures …
Rich Wins Oxbow AwardAugust 10, 2011 Oxbow Animal Health named Gregory Rich, DVM, owner of the West Esplanade Veterinary Clinic in Metairie, La., as the winner of the 2011 Oxbow Exotic Mammal Health Award. The annual award is presented to an animal health professional advancing the field of exotic mammal medicine and care. Dr. Rich was presented with the award on Aug. 7 at the 2011 AAV/AEMV/ARAV conference in Seattle, Wash. “We could not be more excited to recognize Dr. Rich and his contributions to the field of small exotic medicine,” said John Miller, president of Oxbow Animal Health. “Dr. Rich has gone above and beyond the call of duty time and again, putting the health and wellbeing of animals first and foremost in everything he does. It is our hope that the Oxbow Exotic Mammal Health Award may serve to recognize Dr. Rich’s continued legacy of compassion and commitment to animals of all species and sizes.” Rich was a member of the Louisiana State Animal Response Team and Deep Water Horizon/BP Oil Spill Wildlife Response Team, as well as the Jefferson Parish animal welfare committee and South West Veterinary Symposium continuing education program. Rich received the Outstanding Alumnus …
University Of Pennsylvania Vet Researcher Receives GrantAugust 10, 2011 The United Mitochondrial Disease Foundation (UMDF) awarded Brett A. Kaufman, PhD, assistant professor department of animal biology at the University of Pennsylvania School of Veterinary Medicine, a $120,000 grant to study the role mtDNA copy number control plays in the development of disease. Dr. Kaufman’s grant was also selected for the UMDF Chairman’s Award for the top grant this year. “Our aim is to make a rapid and fundamental impact on our understanding of mtDNA regulation in disease,” Kaufman said. “This work will increase our knowledge of molecular mechanisms regulating mtDNA copy number, and potentially, mitochondrial gene expression. With the technical support of collaborators and our departmental expertise, our lab is uniquely situated to conduct the experiments that will answer important questions about mtDNA content control.” Kaufman said this work will allow researchers to better understand the mtDNA depletion syndromes and other complex diseases whose pathogenesis involves mtDNA deletion or depletion, such as neurodegenerative diseases. “We are happy that Dr. Kaufman’s project was selected for UMDF Research Grant funding in 2011,” said Charles A. Mohan, Jr., CEO, executive director of UMDF. “We are excited about the project and we …
